{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:19:59Z","timestamp":1783189199038,"version":"3.54.6"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T00:00:00Z","timestamp":1783123200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-026-05244-8","type":"journal-article","created":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T05:41:21Z","timestamp":1783143681000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictors of residual tumour and recurrence in high-grade NMIBC: insights from a multicenter re-TURBT cohort"],"prefix":"10.1007","author":[{"given":"Mohammad","family":"Jaabou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary","family":"Dovey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osama","family":"Zaytoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modassar","family":"Awan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke","family":"Hildebrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maida","family":"Bada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Signore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Falavolti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Di Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rocco","family":"Papalia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Bellido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad","family":"Rabie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Buscarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,4]]},"reference":[{"issue":"3","key":"5244_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 71(3):209\u2013249","journal-title":"CA Cancer J Clin"},{"issue":"19","key":"5244_CR2","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1001\/jama.2020.17598","volume":"324","author":"AT Lenis","year":"2020","unstructured":"Lenis AT, Lec PM, Chamie K, Mshs MD (2020) Bladder cancer: a review. JAMA 324(19):1980\u20131991","journal-title":"JAMA"},{"issue":"3","key":"5244_CR3","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","volume":"49","author":"RJ Sylvester","year":"2006","unstructured":"Sylvester RJ, van der Meijden APM, Oosterlinck W, Witjes JA, Bouffioux C, Denis L et al (2006) Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 49(3):466\u2013477","journal-title":"Eur Urol"},{"issue":"1","key":"5244_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, Dominguez Escrig JL et al (2022) European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1 and carcinoma in situ). Eur Urol 81(1):75\u201394","journal-title":"Eur Urol"},{"issue":"4","key":"5244_CR5","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","volume":"196","author":"SS Chang","year":"2016","unstructured":"Chang SS, Boorjian SA, Chou R, Clark PE, Daneshmand S, Konety BR et al (2016) Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline. J Urol 196(4):1021\u20131029","journal-title":"J Urol"},{"issue":"6","key":"5244_CR6","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1016\/j.eururo.2018.02.014","volume":"73","author":"MGK Cumberbatch","year":"2018","unstructured":"Cumberbatch MGK, Foerster B, Catto JWF, Kamat AM, Kassouf W, Jubber I et al (2018) Repeat transurethral resection in non-muscle-invasive bladder cancer: a systematic review and meta-analysis. Eur Urol 73(6):925\u2013933","journal-title":"Eur Urol"},{"issue":"5","key":"5244_CR7","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.eururo.2009.12.024","volume":"57","author":"RJ Sylvester","year":"2010","unstructured":"Sylvester RJ, Brausi MA, Kirkels WJ, Hoeltl W, Da Silva FC, Powell PH et al (2010) Long-term efficacy results of EORTC randomized phase III study comparing intravesical bacillus Calmette-Gu\u00e9rin with epirubicin and interferon-alpha in superficial bladder cancer. Eur Urol 57(5):766\u2013773","journal-title":"Eur Urol"},{"issue":"1","key":"5244_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/00005392-199907000-00018","volume":"162","author":"HW Herr","year":"1999","unstructured":"Herr HW (1999) The value of a second transurethral resection in evaluating patients with bladder tumors. J Urol 162(1):74\u201376","journal-title":"J Urol"},{"issue":"1","key":"5244_CR9","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2015.06.045","volume":"69","author":"P Gontero","year":"2016","unstructured":"Gontero P, Sylvester R, Pisano F, Joniau S, Vander Eeckt K, Serretta V et al (2016) The impact of re-transurethral resection on clinical outcomes in a large multi-institutional cohort of patients with T1 high-grade bladder cancer treated with BCG. Eur Urol 69(1):60\u201366","journal-title":"Eur Urol"},{"issue":"4","key":"5244_CR10","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1016\/j.euf.2016.12.011","volume":"4","author":"A Naselli","year":"2018","unstructured":"Naselli A, Hurle R, Paparella S, Buffi N, Lughezzani G, Lista G et al (2018) Role of restaging transurethral resection for T1 non-muscle invasive bladder cancer: a systematic review and meta-analysis. Eur Urol Focus 4(4):558\u2013567","journal-title":"Eur Urol Focus"},{"issue":"5","key":"5244_CR11","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.eururo.2009.05.047","volume":"57","author":"P Mariappan","year":"2010","unstructured":"Mariappan P, Zachou A, Grigor KM (2010) Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol 57(5):843\u2013849","journal-title":"Eur Urol"},{"issue":"5","key":"5244_CR12","first-page":"924","volume":"66","author":"JP Sfakianos","year":"2014","unstructured":"Sfakianos JP, Kim PH, Hakimi AA, Herr HW (2014) The effect of restaging transurethral resection on recurrence and progression rates in patients with T1 bladder cancer. Eur Urol 66(5):924\u2013928","journal-title":"Eur Urol"},{"key":"5244_CR13","doi-asserted-by":"crossref","unstructured":"Ahmadi N, et al. Prediction of recurrence risk in patients with non-muscle-invasive bladder cancer. Asian J Urol. 2024","DOI":"10.1016\/j.ajur.2023.04.007"},{"key":"5244_CR14","doi-asserted-by":"crossref","unstructured":"\u015alusarczyk A, et al. Assessing the predictive accuracy of EORTC, CUETO and EAU risk stratification models for high-grade recurrence and progression after BCG therapy in NMIBC. Cancers (Basel). 2024","DOI":"10.3390\/cancers16091684"},{"key":"5244_CR15","doi-asserted-by":"crossref","unstructured":"Li Y, et al. Prognostic factors in T1 high-grade urothelial carcinoma of the bladder with lymphovascular invasion: a retrospective cohort study. Int Urol Nephrol. 2025","DOI":"10.1007\/s11255-025-04391-8"},{"key":"5244_CR16","doi-asserted-by":"crossref","unstructured":"Ayd\u0131n U, et al. Is the presence of lymphovascular invasion associated with recurrence and progression in bladder cancer patients that have received adequate BCG therapy? Arab J Urol. 2025","DOI":"10.1016\/j.acuroe.2025.501785"},{"issue":"4","key":"5244_CR17","first-page":"606","volume":"64","author":"PN D\u2019Halluin","year":"2013","unstructured":"D\u2019Halluin PN et al (2013) Photodynamic diagnosis for non-muscle-invasive bladder cancer: a systematic review and meta-analysis of its impact on recurrence and progression. Eur Urol 64(4):606\u2013614","journal-title":"Eur Urol"},{"issue":"5","key":"5244_CR18","first-page":"368","volume":"18","author":"Y Naya","year":"2011","unstructured":"Naya Y et al (2011) Narrow-band imaging for detecting residual or recurrent tumor after initial transurethral resection of bladder tumor. Int J Urol 18(5):368\u2013373","journal-title":"Int J Urol"},{"issue":"5","key":"5244_CR19","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","volume":"168","author":"RJ Sylvester","year":"2002","unstructured":"Sylvester RJ, van der Meijden APM, Lamm DL (2002) Intravesical bacillus Calmette-Gu\u00e9rin reduces recurrence in non-muscle-invasive bladder cancer: a meta-analysis of randomized trials. J Urol 168(5):1964\u20131970","journal-title":"J Urol"},{"issue":"4","key":"5244_CR20","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","volume":"163","author":"DL Lamm","year":"2000","unstructured":"Lamm DL, Blumenstein BA, Crissman JD, Montie JE, Gottesman JE, Lowe BA et al (2000) Maintenance bacillus Calmette-Gu\u00e9rin immunotherapy for recurrent Ta, T1 and CIS bladder cancer: a randomized Southwest Oncology Group study. J Urol 163(4):1124\u20131129","journal-title":"J Urol"},{"issue":"4","key":"5244_CR21","first-page":"808","volume":"65","author":"J Oddens","year":"2014","unstructured":"Oddens J, Brausi M, Sylvester R, Bono A, van de Beek C, van Andel G et al (2014) The effect of age on the efficacy of maintenance bacillus Calmette-Gu\u00e9rin in patients with intermediate- and high-risk Ta T1 bladder cancer. Eur Urol 65(4):808\u2013814","journal-title":"Eur Urol"},{"issue":"16","key":"5244_CR22","first-page":"2474","volume":"120","author":"TA Skolarus","year":"2014","unstructured":"Skolarus TA, Zhang Y, Miller DC, Holoshitz N, Hollenbeck BK (2014) The economic burden of bladder cancer: estimates and determinants of medical expenditures. Cancer 120(16):2474\u20132481","journal-title":"Cancer"},{"issue":"6","key":"5244_CR23","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1016\/j.eururo.2011.03.023","volume":"59","author":"A Stenzl","year":"2011","unstructured":"Stenzl A et al (2011) Photodynamic diagnosis of bladder cancer: European Association of Urology guidelines. Eur Urol 59(6):1050\u20131062","journal-title":"Eur Urol"},{"issue":"5","key":"5244_CR24","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1016\/j.eururo.2013.03.059","volume":"64","author":"M Burger","year":"2013","unstructured":"Burger M et al (2013) Photodynamic diagnosis of non\u2013muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence. Eur Urol 64(5):846\u2013854","journal-title":"Eur Urol"},{"issue":"5","key":"5244_CR25","first-page":"1180","volume":"7","author":"A Naselli","year":"2021","unstructured":"Naselli A et al (2021) En bloc transurethral resection of bladder tumors: a systematic review. Eur Urol Focus 7(5):1180\u20131190","journal-title":"Eur Urol Focus"},{"issue":"5","key":"5244_CR26","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/S0302-2838(02)00068-4","volume":"41","author":"M Brausi","year":"2002","unstructured":"Brausi M et al (2002) Variability in the recurrence rate at first follow-up cystoscopy after TUR in NMIBC. Eur Urol 41(5):523\u2013531","journal-title":"Eur Urol"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05244-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-026-05244-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-026-05244-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T18:02:00Z","timestamp":1783188120000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-026-05244-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,4]]},"references-count":26,"alternative-id":["5244"],"URL":"https:\/\/doi.org\/10.1007\/s11255-026-05244-8","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,4]]},"assertion":[{"value":"3 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflicts of interest related to this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}